T. Miyamoto Et Al. , "Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*," LEUKEMIA & LYMPHOMA , vol.63, no.4, pp.928-938, 2022
Miyamoto, T. Et Al. 2022. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*. LEUKEMIA & LYMPHOMA , vol.63, no.4 , 928-938.
Miyamoto, T., Sanford, D., Tomuleasa, C., Hsiao, H., Enciso Olivera, L. J., Kumar Enjeti, A., ... Gimenez Conca, A.(2022). Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*. LEUKEMIA & LYMPHOMA , vol.63, no.4, 928-938.
Miyamoto, Toshihiro Et Al. "Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*," LEUKEMIA & LYMPHOMA , vol.63, no.4, 928-938, 2022
Miyamoto, Toshihiro Et Al. "Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*." LEUKEMIA & LYMPHOMA , vol.63, no.4, pp.928-938, 2022
Miyamoto, T. Et Al. (2022) . "Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*." LEUKEMIA & LYMPHOMA , vol.63, no.4, pp.928-938.
@article{article, author={Toshihiro Miyamoto Et Al. }, title={Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*}, journal={LEUKEMIA & LYMPHOMA}, year=2022, pages={928-938} }